Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curtis Cooper

Showing results (191-200 of 268) with videos related to

Pageof 27
Sort By:
Journal of Viral Hepatitis|January 27, 2025
Association of MASLD Phenotypes With Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk FactorsWesal Elgretli, Mohamed Shengir, Solomon Sasson, et al.
BMC Infectious Diseases|April 13, 2017
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patientsTony Antoniou, Leah Szadkowski, Sharon Walmsley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2016
A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral TherapyJennifer Gillis, Mona Loutfy, Ahmed M Bayoumi, et al.
HIV Clinical Trials|August 22, 2014
Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trialMarina B Klein, Terry Lee, Marie-Josée Brouillette, et al.
Transplantation|March 8, 2016
Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" ExperienceNabiha Faisal, Marc Bilodeau, Bandar Aljudaibi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 10, 2024
Associations of CD4 Cell Count Measures With Infection-Related and Infection-Unrelated Cancer Risk Among People With HIVIoana A Nicolau, Rahim Moineddin, Jennifer D Brooks, et al.
AIDS Care|June 2, 2021
Tobacco smoking and HIV-related immunologic and virologic response among individuals of the Canadian HIV Observational Cohort (CANOC)Alison R McClean, Katherine W Kooij, Jason Trigg, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|March 24, 2015
Hepatitis C virus seroconversion among HIV-positive men who have sex with men with no history of injection drug use: Results from a clinical HIV cohortAnn N Burchell, Sandra L Gardner, Tony Mazzulli, et al.
Canadian Liver Journal|August 22, 2022
Characterization of HCV-infected people who inject drugs (PWID) in the setting of clinical care in Canada (CAPICA): A retrospective studyBrian Conway, Julie Bruneau, Curtis Cooper, et al.
Substance Use & Misuse|June 23, 2018
Hepatitis C Testing, Status and Treatment among Marginalized People Who Use Drugs in an Inner City Setting: An Observational Cohort StudyLisa M Boucher, Ahmed M Bayoumi, Amy E Mark, et al.
Pageof 27

Showing results (191-200 of 268) with videos related to

Sort By:
Pageof 27
Journal of Viral Hepatitis|January 27, 2025
Association of MASLD Phenotypes With Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk FactorsWesal Elgretli, Mohamed Shengir, Solomon Sasson, et al.
BMC Infectious Diseases|April 13, 2017
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patientsTony Antoniou, Leah Szadkowski, Sharon Walmsley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 17, 2016
A Multi-State Model Examining Patterns of Transitioning Among States of Engagement in Care in HIV-Positive Individuals Initiating Combination Antiretroviral TherapyJennifer Gillis, Mona Loutfy, Ahmed M Bayoumi, et al.
HIV Clinical Trials|August 22, 2014
Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trialMarina B Klein, Terry Lee, Marie-Josée Brouillette, et al.
Transplantation|March 8, 2016
Sofosbuvir-Based Antiviral Therapy Is Highly Effective In Recurrent Hepatitis C in Liver Transplant Recipients: Canadian Multicenter "Real-Life" ExperienceNabiha Faisal, Marc Bilodeau, Bandar Aljudaibi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 10, 2024
Associations of CD4 Cell Count Measures With Infection-Related and Infection-Unrelated Cancer Risk Among People With HIVIoana A Nicolau, Rahim Moineddin, Jennifer D Brooks, et al.
AIDS Care|June 2, 2021
Tobacco smoking and HIV-related immunologic and virologic response among individuals of the Canadian HIV Observational Cohort (CANOC)Alison R McClean, Katherine W Kooij, Jason Trigg, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|March 24, 2015
Hepatitis C virus seroconversion among HIV-positive men who have sex with men with no history of injection drug use: Results from a clinical HIV cohortAnn N Burchell, Sandra L Gardner, Tony Mazzulli, et al.
Canadian Liver Journal|August 22, 2022
Characterization of HCV-infected people who inject drugs (PWID) in the setting of clinical care in Canada (CAPICA): A retrospective studyBrian Conway, Julie Bruneau, Curtis Cooper, et al.
Substance Use & Misuse|June 23, 2018
Hepatitis C Testing, Status and Treatment among Marginalized People Who Use Drugs in an Inner City Setting: An Observational Cohort StudyLisa M Boucher, Ahmed M Bayoumi, Amy E Mark, et al.
Pageof 27